Katherine Ruzhansky

Concepts (61)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Amyloid Neuropathies, Familial
2
2017
21
0.620
 Why?
Neuromuscular Diseases
1
2015
14
0.520
 Why?
Myasthenia Gravis
3
2021
17
0.510
 Why?
Threonine
1
2014
47
0.480
 Why?
Prealbumin
1
2014
25
0.480
 Why?
Twins, Monozygotic
1
2014
27
0.480
 Why?
Lysine
1
2014
96
0.470
 Why?
Graft vs Host Disease
1
2015
163
0.440
 Why?
Hematopoietic Stem Cell Transplantation
1
2015
245
0.430
 Why?
Physicians
3
2022
324
0.400
 Why?
Receptors, Cholinergic
2
2019
30
0.310
 Why?
Receptor Protein-Tyrosine Kinases
2
2019
100
0.300
 Why?
Postoperative Complications
1
2015
1615
0.300
 Why?
Drugs, Investigational
1
2022
18
0.200
 Why?
Adverse Drug Reaction Reporting Systems
1
2022
42
0.200
 Why?
Nervous System Diseases
1
2022
142
0.190
 Why?
Patient Reported Outcome Measures
1
2022
114
0.180
 Why?
Rituximab
2
2019
61
0.180
 Why?
Physical Examination
1
2021
152
0.180
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2022
148
0.180
 Why?
Thymectomy
1
2019
11
0.160
 Why?
Patient Education as Topic
1
2021
425
0.160
 Why?
Neurologists
1
2017
15
0.150
 Why?
Diagnostic Techniques, Neurological
1
2017
6
0.150
 Why?
Oligonucleotides
1
2017
34
0.150
 Why?
Immunologic Factors
1
2017
87
0.140
 Why?
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
2015
3
0.130
 Why?
Neuromuscular Junction Diseases
1
2015
1
0.130
 Why?
Paraproteinemias
1
2015
4
0.130
 Why?
4-Aminopyridine
1
2015
5
0.130
 Why?
Orphan Drug Production
1
2015
3
0.130
 Why?
Potassium Channel Blockers
1
2015
32
0.130
 Why?
Peripheral Nervous System Diseases
1
2015
37
0.130
 Why?
Severity of Illness Index
2
2017
1851
0.120
 Why?
Autoantibodies
1
2017
434
0.120
 Why?
Telemedicine
1
2021
700
0.110
 Why?
Phenotype
1
2014
947
0.100
 Why?
Middle Aged
6
2022
21147
0.090
 Why?
Humans
9
2022
68618
0.080
 Why?
Female
7
2022
38074
0.080
 Why?
Prednisone
2
2019
104
0.080
 Why?
Adult
5
2022
21403
0.060
 Why?
Male
6
2022
37321
0.050
 Why?
Cohort Studies
2
2019
2358
0.050
 Why?
Immunoglobulins, Intravenous
1
2019
52
0.040
 Why?
Age of Onset
1
2019
188
0.040
 Why?
Neural Conduction
1
2017
24
0.040
 Why?
Aged
3
2019
14862
0.040
 Why?
Aged, 80 and over
2
2017
4848
0.040
 Why?
International Cooperation
1
2017
88
0.040
 Why?
Single-Blind Method
1
2017
249
0.040
 Why?
Treatment Outcome
2
2019
7029
0.030
 Why?
Young Adult
2
2019
5717
0.030
 Why?
Anti-Inflammatory Agents
1
2017
234
0.030
 Why?
Disability Evaluation
1
2017
298
0.030
 Why?
Retrospective Studies
2
2019
7277
0.030
 Why?
Surveys and Questionnaires
1
2022
2800
0.030
 Why?
Follow-Up Studies
1
2017
3259
0.020
 Why?
Prospective Studies
1
2017
3705
0.020
 Why?
Child
1
2019
6405
0.020
 Why?
Adolescent
1
2019
8912
0.020
 Why?
Ruzhansky's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (61)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_